Rosenblatt Securities Reaffirms Buy Rating for Dolby Laboratories (NYSE:DLB)

Dolby Laboratories (NYSE:DLB)‘s stock had its “buy” rating restated by research analysts at Rosenblatt Securities in a note issued to investors on Friday,Benzinga reports. They currently have a $85.00 price target on the electronics maker’s stock. Rosenblatt Securities’ price objective would suggest a potential upside of 32.42% from the stock’s current price.

DLB has been the subject of a number of other research reports. Barrington Research dropped their price objective on Dolby Laboratories from $95.00 to $90.00 and set an “outperform” rating for the company in a research note on Monday, January 26th. Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a report on Monday, December 29th. Finally, Wall Street Zen raised shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a research note on Monday, January 5th. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $90.75.

Dolby Laboratories Price Performance

DLB stock opened at $64.19 on Friday. The stock has a market cap of $6.13 billion, a PE ratio of 25.88 and a beta of 0.88. Dolby Laboratories has a one year low of $60.14 and a one year high of $85.49. The firm has a 50 day simple moving average of $65.07 and a two-hundred day simple moving average of $68.84.

Dolby Laboratories (NYSE:DLB) last announced its quarterly earnings data on Thursday, January 29th. The electronics maker reported $1.06 EPS for the quarter, beating the consensus estimate of $0.99 by $0.07. The firm had revenue of $346.71 million for the quarter, compared to the consensus estimate of $341.26 million. Dolby Laboratories had a net margin of 17.97% and a return on equity of 11.49%. The company’s revenue was down 2.8% on a year-over-year basis. During the same period last year, the firm earned $1.14 EPS. On average, research analysts expect that Dolby Laboratories will post 2.94 EPS for the current fiscal year.

Insider Buying and Selling at Dolby Laboratories

In other Dolby Laboratories news, SVP Shriram Revankar sold 3,000 shares of the business’s stock in a transaction that occurred on Friday, November 21st. The stock was sold at an average price of $65.55, for a total transaction of $196,650.00. Following the sale, the senior vice president directly owned 67,435 shares of the company’s stock, valued at $4,420,364.25. The trade was a 4.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP John D. Couling sold 7,273 shares of the company’s stock in a transaction that occurred on Thursday, December 11th. The shares were sold at an average price of $68.75, for a total value of $500,018.75. Following the sale, the senior vice president owned 108,065 shares in the company, valued at approximately $7,429,468.75. This trade represents a 6.31% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 137,120 shares of company stock valued at $9,184,809. Corporate insiders own 37.93% of the company’s stock.

Institutional Trading of Dolby Laboratories

Several hedge funds and other institutional investors have recently bought and sold shares of DLB. First Horizon Corp purchased a new position in Dolby Laboratories during the third quarter worth $25,000. Hantz Financial Services Inc. lifted its holdings in shares of Dolby Laboratories by 166.7% in the 3rd quarter. Hantz Financial Services Inc. now owns 352 shares of the electronics maker’s stock worth $25,000 after acquiring an additional 220 shares during the last quarter. Allworth Financial LP lifted its holdings in shares of Dolby Laboratories by 590.4% in the 2nd quarter. Allworth Financial LP now owns 504 shares of the electronics maker’s stock worth $37,000 after acquiring an additional 431 shares during the last quarter. Mather Group LLC. purchased a new position in shares of Dolby Laboratories during the 3rd quarter worth about $38,000. Finally, Rothschild Investment LLC grew its holdings in Dolby Laboratories by 4,046.7% during the 3rd quarter. Rothschild Investment LLC now owns 622 shares of the electronics maker’s stock valued at $45,000 after purchasing an additional 607 shares during the last quarter. Hedge funds and other institutional investors own 58.56% of the company’s stock.

More Dolby Laboratories News

Here are the key news stories impacting Dolby Laboratories this week:

• Positive Sentiment: Company raised FY‑2026 and Q2 guidance well above Street estimates (FY EPS 4.30–4.45 vs. consensus ~3.79; Q2 EPS 1.29–1.44). The stronger outlook is the main catalyst supporting the stock today.
• Positive Sentiment: Dolby announced a quarterly dividend of $0.36 per share (yield ~2.3%), which can attract income-oriented investors and support the share price around the ex‑dividend date.
• Positive Sentiment: Rosenblatt reaffirmed a “Buy” rating with an $85 price target, adding analyst support and upside narrative for investors. Benzinga
• Neutral Sentiment: Q1 results beat consensus on EPS ($1.06 vs. ~$0.99) and revenue (~$346.7M vs. ~341M), indicating operational resilience even as some metrics softened. PR Newswire
• Negative Sentiment: Revenue and EPS were down year-over-year (revenue down ~2.8%), driven by weaker licensing, which triggered an after‑hours selloff after the print and remains a near-term risk. Zacks
• Negative Sentiment: Operational and cash-flow pressures were noted (operating profit and net income declined; temporary negative operating cash flow and higher capex flagged by third‑party summaries), which could weigh on near‑term margins and investor sentiment. Quiver Quant

About Dolby Laboratories

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.